Related Experiment Video

Updated: Jun 16, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Validation of anti-aging drugs by treating age-related diseases

Mikhail V Blagosklonny1

  • 1Cancer Center, Ordway Research Institute, Albany, NY 12208, USA.

Aging
|February 17, 2010
PubMed

Insights

This study identifies age-related diseases as key biomarkers for aging. Retrospective analysis reveals four potential drug modalities that could delay these diseases and extend human lifespan.

Area of Science:

  • Gerontology and Longevity Research
  • Translational Medicine
  • Biomarker Discovery

Background:

  • Aging is a primary risk factor for numerous chronic diseases, significantly impacting human lifespan.
  • Age-related diseases, including atherosclerosis, cancer, and neurodegenerative disorders, represent critical targets for intervention.
  • Currently, no single biomarker effectively captures the multifaceted nature of the aging process.

Purpose of the Study:

  • To identify effective anti-aging strategies by evaluating drugs targeting age-related diseases.
  • To establish age-related diseases as reliable biomarkers for assessing anti-aging drug efficacy.
  • To validate potential anti-aging drug effects across a spectrum of chronic conditions.

Main Methods:

  • Retrospective analysis of existing clinical and preclinical data.
  • Utilizing large patient cohorts to evaluate drug effects across multiple age-related diseases simultaneously.
  • Assessing the impact of therapeutic interventions on diverse chronic conditions.

Main Results:

  • Four distinct therapeutic modalities show potential as anti-aging interventions.
  • Age-related diseases collectively serve as a robust biomarker for aging.
  • Simultaneous evaluation of drug effects on multiple diseases can accelerate anti-aging validation.

Conclusions:

  • Targeting age-related diseases offers a viable pathway to extend human lifespan.
  • A multi-disease evaluation approach can efficiently validate anti-aging drug candidates.
  • Further research into the identified modalities is warranted to confirm their anti-aging potential.
Keywords:
anti-aging drugsatherosclerosiscancerdiseasesmetforminrapamycinresveratrol

More Related Videos

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...